Diagnostics firm secures €2m for blood test for pregnant women
Company: Metabolomic Diagnostics
Done Deal:€2 million EU funding
The clincher:“We plan to market the product next year, and with this support from EU, we believe that PrePsia has the potential to become part of pregnancy screening programmes worldwide” - Charles Garvey, chief executive, Metabolomic Diagnostics
Subscribe from just €1 for the first month!
What's Included
With any subscription you will have access to
-
Unlimited multi-device access to our iPad, iPhone and Android Apps
-
Unlimited access to our eReader library
-
Exclusive daily insight and opinion seven days a week
-
Create alerts to never miss a subject that matters to you
-
Get access to exclusive offers for subscribers on gifts and experiences
-
Get content from Business Post, Business Post Magazines, Connected, Tatler and Food & Wine
Related Stories
Content is king – just ask Netflix as rivals attempt to steal its crown
A WarnerMedia-Discovery deal puts the spotlight on streaming wars as around 100 platforms vie for the attention of often fickle audiences
Tom Maguire: Tax changes we make now could help business for years
The way we did business a few months ago may never return – so the opportunity is to make changes that will both aid recovery and set us up well for our new futures
The Daily Briefing
What’s coming up today and what you might have missed
